µÚËÄÒ½¿Æ´óѧ1998ÄêÃâÒßѧ£¨×¨»ù£©£¨²©Ê¿£© A !x"*
1.]#FJe
Ò»¡¢Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© L Lm{:T7
1¡¢Co-stimulators (or co-stimulating molecules) (G*--+Gn
2¡¢NK-kB ZjF$zVk
3¡¢Immunoglobulin superfamily RgZBh04q
4¡¢antigen-presenting cell (APC) pdngM8n
5¡¢death domain y9?B vPp+
6¡¢CCR and CXCR %e+hM $Q
7¡¢Lectin (or mitogen) !LVWggk1
8¡¢Clusters of differentiation, CD) "[q/2vC
9¡¢B7 family j*Ta?'*
10¡¢Cytotoxic T lymphocyte, CTL) f
nX!wN
11¡¢IL-15 and IL-15 receptor (IL-15R) J$%mG*Y(
12¡¢MHC restriction {Nuwz|Ci
13¡¢Affinity-chromatography No=Ig-It
14¡¢Cyctosprin A, CsA s7A{<>:
15¡¢Antibody-dependent cell-mediated cytotoxicity, ADCC) 3?|Fn8dQR.
|CexP^;!U
¶þ¡¢¼ò´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© 0m(/hK
1¡¢ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 V7G?i\>
2¡¢ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ %M2.h;9]*\
3¡¢ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ v7&e,:r2E@
/V+N
Èý¡¢ÎÊ´ðÌ⣨25·Ö£© I,(m\NalK
1¡¢Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ @Kd1|K
ѪҺ²¡Ñ§×¨Òµ£º ~}q"M[{
2¡¢ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿